| 1 |
Selway CA, Jensen ED, Pena AS, Smart G, Weyrich LS. Type 1 diabetes, periodontal health, and a familial history of hyperlipidaemia is associated with oral microbiota in children: a cross-sectional study. BMC Oral Health 2023;23:15. [PMID: 36631887 DOI: 10.1186/s12903-022-02625-0] [Reference Citation Analysis]
|
| 2 |
Morse ZJ, Simister RL, Crowe SA, Horwitz MS, Osborne LC. Virus induced dysbiosis promotes type 1 diabetes onset. Front Immunol 2023;14:1096323. [PMID: 36742327 DOI: 10.3389/fimmu.2023.1096323] [Reference Citation Analysis]
|
| 3 |
Levi Mortera S, Marzano V, Vernocchi P, Matteoli MC, Guarrasi V, Gardini S, Del Chierico F, Rapini N, Deodati A, Fierabracci A, Cianfarani S, Putignani L. Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study. Int J Mol Sci 2022;23. [PMID: 36555624 DOI: 10.3390/ijms232415982] [Reference Citation Analysis]
|
| 4 |
Meena K, Visarada K, Meena D. Sorghum bicolor (L.) Moench a multifarious crop -fodder to therapeutic potential and biotechnological applications: A future food for the millennium. Future Foods 2022;6:100188. [DOI: 10.1016/j.fufo.2022.100188] [Reference Citation Analysis]
|
| 5 |
Del Chierico F, Rapini N, Deodati A, Matteoli MC, Cianfarani S, Putignani L. Pathophysiology of Type 1 Diabetes and Gut Microbiota Role. Int J Mol Sci 2022;23. [PMID: 36498975 DOI: 10.3390/ijms232314650] [Reference Citation Analysis]
|
| 6 |
Du C, Whiddett RO, Buckle I, Chen C, Forbes JM, Fotheringham AK. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells 2022;11:3503. [DOI: 10.3390/cells11213503] [Reference Citation Analysis]
|
| 7 |
Sargin P, Roethle MF, Jia S, Pant T, Ciecko AE, Atkinson SN, Salzman NH, Teng RJ, Chen YG, Cabrera SM, Hessner MJ. Lactiplantibacillus plantarum 299v supplementation modulates β-cell ER stress and antioxidative defense pathways and prevents type 1 diabetes in gluten-free BioBreeding rats. Gut Microbes 2022;14:2136467. [PMID: 36261888 DOI: 10.1080/19490976.2022.2136467] [Reference Citation Analysis]
|
| 8 |
Luo S, Yue T, Liu Z, Yang D, Xu M, Ding Y, Jiang W, Xu W, Yan J, Weng J, Zheng X. Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA. Front Endocrinol 2022;13:938358. [DOI: 10.3389/fendo.2022.938358] [Reference Citation Analysis]
|
| 9 |
Wang L, Xu H, Yang H, Zhou J, Zhao L, Zhang F. Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases. Front Immunol 2022;13:952398. [DOI: 10.3389/fimmu.2022.952398] [Reference Citation Analysis]
|
| 10 |
Wrigley-carr HE, van Dorst JM, Ooi CY. Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes. Medicine in Microecology 2022;13:100057. [DOI: 10.1016/j.medmic.2022.100057] [Reference Citation Analysis]
|
| 11 |
Aggarwal N, Koh EWC, Srivastava SK, Sieow BFL, Hwang IY. Microbiome Engineering for Metabolic Disorders. Principles in Microbiome Engineering 2022. [DOI: 10.1002/9783527825462.ch2] [Reference Citation Analysis]
|
| 12 |
Elsherbiny NM, Ramadan M, Abu Faddan NH, Hassan EA, Ali ME, Abd El-Rehim ASE, Abbas WA, Abozaid MAA, Hassanin E, Mohamed GA, Hetta HF, Salah M. Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study. Int J Gen Med 2022;15:6173-87. [PMID: 35864993 DOI: 10.2147/IJGM.S361169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Morse ZJ, Simister RL, Crowe SA, Horwitz MS, Osborne LC. Virus Infection Causes Dysbiosis to Promote Type 1 Diabetes Onset.. [DOI: 10.1101/2022.07.08.499212] [Reference Citation Analysis]
|
| 14 |
Thakur PS, Aggarwal D, Takkar B, Shivaji S, Das T. Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2022;63:21. [PMID: 35877085 DOI: 10.1167/iovs.63.8.21] [Reference Citation Analysis]
|
| 15 |
Tougaard NH, Frimodt-møller M, Salmenkari H, Stougaard EB, Zawadzki AD, Mattila IM, Hansen TW, Legido-quigley C, Hörkkö S, Forsblom C, Groop P, Lehto M, Rossing P. Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. JCM 2022;11:3573. [DOI: 10.3390/jcm11133573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Martens P, Centelles-lodeiro J, Ellis D, Cook DP, Sassi G, Verlinden L, Verstuyf A, Raes J, Mathieu C, Gysemans C. High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice. Front Immunol 2022;13:902678. [DOI: 10.3389/fimmu.2022.902678] [Reference Citation Analysis]
|
| 17 |
Ternák G, Németh M, Rozanovic M, Bogár L. Antibiotic Consumption Patterns in European Countries Might Be Associated with the Prevalence of Type 1 and 2 Diabetes. Front Endocrinol 2022;13:870465. [DOI: 10.3389/fendo.2022.870465] [Reference Citation Analysis]
|
| 18 |
Bedi S, Richardson TM, Jia B, Saab H, Brinkman FSL, Westley M. Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes. PLoS One 2022;17:e0261103. [PMID: 35196314 DOI: 10.1371/journal.pone.0261103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Tu H, Xiao E, Liu O. Taking Microbiota into Consideration in Mesenchymal Stem Cell Research. J Dent Res 2022;:220345221077986. [PMID: 35196924 DOI: 10.1177/00220345221077986] [Reference Citation Analysis]
|
| 20 |
Craciun C, Neag M, Catinean A, Mitre A, Rusu A, Bala C, Roman G, Buzoianu A, Muntean D, Craciun A. The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus. Biomedicines 2022;10:308. [DOI: 10.3390/biomedicines10020308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 21 |
de Oliveira GLV. Intestinal Dysbiosis in Autoimmune Diseases. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00038-3] [Reference Citation Analysis]
|
| 22 |
de Salis LVV, Martins LS, Rodrigues GSP, de Oliveira GLV. Dysbiosis and probiotic applications in autoimmune diseases. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-12-824390-9.00004-9] [Reference Citation Analysis]
|
| 23 |
Akram M, Riaz T, Elbossaty WF, Zafar S, Munir N, Saeed MM. Microorganisms in the Pathogenesis and Management of Type 1 Diabetes (T1D). Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_22] [Reference Citation Analysis]
|
| 24 |
Sharma VK, Singh TG, Dhiman S, Garg N. Mechanisms of Beneficial Effects of Probiotics in Diabetes Mellitus. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-8444-9_6] [Reference Citation Analysis]
|
| 25 |
Fernández-edreira D, Liñares-blanco J, Fernandez-lozano C. Machine Learning analysis of the human infant gut microbiome identifies influential species in type 1 diabetes. Expert Systems with Applications 2021;185:115648. [DOI: 10.1016/j.eswa.2021.115648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 26 |
Bedi S, Richardson TM, Jia B, Saab H, Brinkman FS, Westley M. Similarities Between Bacterial GAD and Human GAD65: Implications in Gut Mediated Autoimmune Type 1 Diabetes.. [DOI: 10.1101/2021.11.29.470330] [Reference Citation Analysis]
|
| 27 |
Mokhtari P, Metos J, Anandh Babu PV. Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges. Gut Microbes 2021;13:1-18. [PMID: 34101547 DOI: 10.1080/19490976.2021.1926841] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 28 |
Moskovitz M, Nassar M, Moriel N, Cher A, Faibis S, Ram D, Zangen D, Yassour M, Steinberg D. Characterization of the Oral Microbiome Among Children With Type 1 Diabetes Compared With Healthy Children. Front Microbiol 2021;12:756808. [PMID: 34777313 DOI: 10.3389/fmicb.2021.756808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Morse ZJ, Horwitz MS. Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes. Front Immunol 2021;12:751337. [PMID: 34721424 DOI: 10.3389/fimmu.2021.751337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Cayabyab F, Nih LR, Yoshihara E. Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes. Front Endocrinol (Lausanne) 2021;12:732431. [PMID: 34589059 DOI: 10.3389/fendo.2021.732431] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 31 |
Tsai YW, Dong JL, Jian YJ, Fu SH, Chien MW, Liu YW, Hsu CY, Sytwu HK. Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases. Microorganisms 2021;9:1930. [PMID: 34576825 DOI: 10.3390/microorganisms9091930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Gardner G, Fraker CA. Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology. Front Immunol 2021;12:722979. [PMID: 34489972 DOI: 10.3389/fimmu.2021.722979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 33 |
Ternák G, Berényi K, Kun S, Szigeti N, Decsi T, Sütő G, Wittmann I. Inverse association between use of broad spectrum penicllin with beta-lactamase inhibitors and prevalence of type 1 diabetes mellitus in Europe. Sci Rep 2021;11:16768. [PMID: 34408224 DOI: 10.1038/s41598-021-96301-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 34 |
Turroni F, Milani C, Ventura M, van Sinderen D. The human gut microbiota during the initial stages of life: insights from bifidobacteria. Curr Opin Biotechnol 2021;73:81-7. [PMID: 34333445 DOI: 10.1016/j.copbio.2021.07.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 35 |
Woodford KB. Casomorphins and Gliadorphins Have Diverse Systemic Effects Spanning Gut, Brain and Internal Organs. Int J Environ Res Public Health 2021;18:7911. [PMID: 34360205 DOI: 10.3390/ijerph18157911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front Immunol 2021;12:642166. [PMID: 34163468 DOI: 10.3389/fimmu.2021.642166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 37 |
Lakshmanan AP, Shatat IF, Zaidan S, Jacob S, Bangarusamy DK, Al-Abduljabbar S, Al-Khalaf F, Petroviski G, Terranegra A. Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus. Biomed Pharmacother 2021;140:111736. [PMID: 34034069 DOI: 10.1016/j.biopha.2021.111736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
Botía-Sánchez M, Alarcón-Riquelme ME, Galicia G. B Cells and Microbiota in Autoimmunity. Int J Mol Sci 2021;22:4846. [PMID: 34063669 DOI: 10.3390/ijms22094846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 39 |
Yehualashet AS, Yikna BB. Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System. Diabetes Metab Syndr Obes 2021;14:1841-54. [PMID: 33953584 DOI: 10.2147/DMSO.S304497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 40 |
Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 41 |
Gradisteanu Pircalabioru G, Corcionivoschi N, Gundogdu O, Chifiriuc MC, Marutescu LG, Ispas B, Savu O. Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies. Int J Mol Sci 2021;22:2763. [PMID: 33803255 DOI: 10.3390/ijms22052763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 42 |
Zhou H, Sun L, Zhang S, Zhao X, Gang X, Wang G. The crucial role of early-life gut microbiota in the development of type 1 diabetes. Acta Diabetol 2021;58:249-65. [PMID: 32712802 DOI: 10.1007/s00592-020-01563-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 43 |
Bassin EJ, Piganelli JD, Little SR. Auto-antigen and Immunomodulatory Agent-Based Approaches for Antigen-Specific Tolerance in NOD Mice. Curr Diab Rep 2021;21:9. [PMID: 33547977 DOI: 10.1007/s11892-021-01376-6] [Reference Citation Analysis]
|
| 44 |
Knudsen JK, Leutscher P, Sørensen S. Gut Microbiota in Bone Health and Diabetes. Curr Osteoporos Rep 2021;19:462-79. [PMID: 33523423 DOI: 10.1007/s11914-020-00629-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 45 |
Barengolts E, Smith ED. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review. Endocr Pract 2020;26:1186-95. [PMID: 33471720 DOI: 10.4158/EP-2020-0336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 46 |
Klein BY. Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone. Vaccine 2020;38:6427-34. [PMID: 32773242 DOI: 10.1016/j.vaccine.2020.07.066] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 47 |
Predieri B, Bruzzi P, Bigi E, Ciancia S, Madeo SF, Lucaccioni L, Iughetti L. Endocrine Disrupting Chemicals and Type 1 Diabetes. Int J Mol Sci. 2020;21. [PMID: 32331412 DOI: 10.3390/ijms21082937] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
